Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment

NCT02365402 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Entecavir

Sponsor

Beijing Ditan Hospital